VRNA – verona pharma plc - american depositary shares (US:NASDAQ)

News

Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveInsight
Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveInsight
Verona Pharma Announces December 2024 Investor Conference Participation [Yahoo! Finance]
Verona Pharma Announces December 2024 Investor Conference Participation
Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com